RNS Number : 6252R
LMS Capital PLC
29 October 2023
 

Logo Description automatically generated

 

 

 

 

 

 

 

 







30 October 2023

 

LMS CAPITAL PLC

Third Quarter 2023 Update

 

LMS Capital plc (the "Company") the listed Investment Company, provides the following update covering the period from 30 June 2023 to date.

 

Financial Highlights

·    Unaudited Net Asset Value ("NAV") at 30 September 2023 was £42.7 million (52.9p per share). This compares to £44.6 million (55.2p per share) at 30 June 2023, a decrease in the quarter of 3.8% after adjusting for dividends paid;

·    Interim dividend of £0.2 million (0.3p per share) paid in September 2023; and

·    Cash at 30 September 2023 was £16.0 million (19.9p per share) compared to £16.5 million (20.4p per share) at 30 June 2023.

 

Unaudited Net Asset Value at 30 September 2023

The 30 September 2023 NAV is summarised below:


 Unaudited

 30 September 2023

Unaudited

30 June 2023


£ 000s

Mature Investment Portfolio



Quoted Investments

128

161

Unquoted Investments

6,357

6,668

Funds

11,976

13,663


18,461

20,492

New Investment Portfolio



Dacian

10,061

9,660


10,061

9,660




Total Investments

28,522

30,152

Cash

16,038

16,500

Other Net Assets/Liabilities 

(1,892)

(2,070)

Net Asset Value

42,668

44,582


The NAV at the end of September is based on the valuation of the Company's investments as at 30 June 2023, adjusted for transactions in the three months ended 30 September 2023, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, and the latest information available from third party fund managers.

 

The £1.9 million decrease in NAV during the third quarter comprises:

·    dividend payments of £0.2 million;

·    net income and fair value adjustments on the investment portfolio result in an overall valuation decrease of £1.4 million in the investment portfolio:

net decreases in underlying investment values of £2.4 million on the mature asset portfolio;

offset by net increase of £1.0 million from foreign exchange gains from the strengthening of the US Dollar against sterling of which £0.6 million relates to the mature portfolio and £0.4 million to the investment in Dacian; and

no net underlying increase or decrease in the value of Dacian. The production difficulties experienced at Dacian earlier in the year and referenced in the half year report, have been overcome and Dacian management expect production levels to increase;

·    bank interest of £0.2 million; and

·    running costs of £0.4 million, and investment related costs of £0.1 million principally associated with developing real estate deal opportunities.

 

Portfolio Net Underlying Losses

The principal portfolio investments are summarised in Note 1 below.

 

Quoted Investments

The Company's quoted investment valuations remained flat during the third quarter.

 

Unquoted Investments

The Company's unquoted investments include our direct holdings in Dacian Petroleum, Medhost and Elateral.  The convertible debt instrument with Tiallis Essential IT plc was redeemed at book value during the quarter realising proceeds of £0.1 million.

 

Unrealised losses on the unquoted portfolio were £0.5 million during the third quarter and all arose in relation to Medhost, reflecting movements in comparable public company valuations.

 

Funds

The Company's fund investments include its holding in Brockton Capital Fund I, Opus Capital Venture Partners, Weber Capital Partners and five other smaller fund interests.

 

Fund unrealised net losses were £1.9 million during the period. The principal movements were:

·    Brockton Capital Fund 1 - Unrealised loss of £1.5 million, reflecting a potentially extended sales programme in the current market;

·    Weber Capital Partners - Unrealised loss of £0.4 million due to the performance in the U.S. microcap equities held in the fund; and

·    other fund investments remained flat during the third quarter.

 

The carrying value of the funds is based on the latest available information from the respective fund managers, generally the 30 June 2023 fund valuation reports except for Weber Capital Partners, which is based on 30 September 2023 valuations.

 

Liquidity and Outlook

Portfolio realisations were £0.1 million during the period.  Cash balances were £16.0 million at 30 September 2023.

 

The Board remains cognisant of its responsibility to demonstrate positive progress and to create value for shareholders through delivery in its core areas, namely:

·    bringing to fruition the work that has been undertaken, particularly on real estate, to deploy new capital from the Company's balance sheet in conjunction with co-investors;

·    to support the Dacian team, with an emphasis on restarting its workover programme, following the interruptions to production earlier in the year; and

·    continuing to manage the mature asset portfolio to optimise realisation proceeds.

 

 

The information contained in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please contact:

LMS Capital plc - Nick Friedlos, Managing Director

0207 935 3555

 

Shore Capital - Robert Finlay

0207 408 4050

 

 

 



 

Note 1 - Portfolio Overview

The following are the principal portfolio investments of the Company, representing 97.1% of the total portfolio value:

 

Principal unquoted investments

Dacian Petroleum

REGION: EU | YEAR: 2021 | % Holding 32% | NAV £10.1 million (31 December 2022: £10.1 million)

Dacian is a Romanian oil and natural gas production company which completed its first acquisition in 2021. It operates approximately 100 producing wells across 40 onshore oil and gas fields in Romania. These are late-life assets, and the business plan is to prolong the life of this established industrial infrastructure through careful management and investment in a program of work-over projects designed to increase production.

 

Medhost

REGION: US | YEAR: 2008 | % Holding 8.8% | NAV £5.7 million (31 December 2022: £5.7 million)

Medhost, a co-investment with funds of Primus Capital, is a healthcare information technology group that provides cloud-based enterprise, departmental and healthcare engagement solutions to over 1,000 community and specialty hospitals. Its products include cloud-based clinical, financial and operational solutions as well as maintenance, support and consulting services.

 

Elateral

REGION: UK | YEAR: 2008 | % Holding 62.5% | NAV £0.6 million (31 December 2022: £0.6 million)

Elateral operates in the digital marketing sector and has developed cloud-based software which allows corporate marketing materials to be distributed to local marketing teams to enable content to be tailored whilst protecting brand identity. Elateral targets both SME's and large international companies and has a strong list of global corporate customers.

 

Principal funds

Brockton Capital Fund I

REGION: UK | YEAR: 2008 | NAV £4.9 million (31 December 2022: £6.0 million)

Brockton is a UK real estate fund with one remaining investment in a super prime London residential development. The Company's investment represents its share of preferred debt investments via the Brockton fund.

 

Opus Capital Venture Partners

REGION: UK | YEAR: 2008 | NAV £4.4 million (31 December 2022: £5.3 million)

Opus is a US fund that invests in early-stage technology opportunities with two principal assets remaining.

 

Weber Capital Partners

REGION: US | YEAR: 2008 | NAV £2.0 million (31 December 2022: £2.0 million)

Weber Capital GW 2001 is a fund that invests in listed U.S. microcap stocks, primarily in the technology and medical sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVMLBBTMTITTFJ